Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Erben

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Plos One|March 12, 2021
A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancerDaniel Uysal, Karl-Friedrich Kowalewski, Maximilian Christian Kriegmair, et al.
Oncology Letters|April 14, 2016
Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expressionClaudia Umbreit, Philipp Erben, Anne Faber, et al.
Urologia Internationalis|January 19, 2016
Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and GemcitabineFelix Wezel, Philipp Erben, Timo Gaiser, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 7, 2021
Factors to improve academic publishing success of physicians engaged in scientific researchManuel Neuberger, Christel Weiß, Thomas Stefan Worst, et al.
Aktuelle Urologie|July 28, 2017
[Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance]Philipp Erben, Felix Wezel, Ralph Wirtz, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7Christian Bolenz, Daniel Knauf, Axel John, et al.
Haematologica|July 8, 2008
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaThomas Ernst, Jana Hoffmann, Philipp Erben, et al.
Cancers|November 27, 2019
<i>ANLN</i> and <i>TLE2</i> in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro DataSheng Wu, Katja Nitschke, Jakob Heinkele, et al.
Scientific Reports|November 25, 2020
Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancerSebastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, et al.
Journal of Cancer Research and Clinical Oncology|November 18, 2011
Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicityNicolai Härtel, Thomas Klag, Benjamin Hanfstein, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Plos One|March 12, 2021
A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancerDaniel Uysal, Karl-Friedrich Kowalewski, Maximilian Christian Kriegmair, et al.
Oncology Letters|April 14, 2016
Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expressionClaudia Umbreit, Philipp Erben, Anne Faber, et al.
Urologia Internationalis|January 19, 2016
Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and GemcitabineFelix Wezel, Philipp Erben, Timo Gaiser, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 7, 2021
Factors to improve academic publishing success of physicians engaged in scientific researchManuel Neuberger, Christel Weiß, Thomas Stefan Worst, et al.
Aktuelle Urologie|July 28, 2017
[Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance]Philipp Erben, Felix Wezel, Ralph Wirtz, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7Christian Bolenz, Daniel Knauf, Axel John, et al.
Haematologica|July 8, 2008
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaThomas Ernst, Jana Hoffmann, Philipp Erben, et al.
Cancers|November 27, 2019
<i>ANLN</i> and <i>TLE2</i> in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro DataSheng Wu, Katja Nitschke, Jakob Heinkele, et al.
Scientific Reports|November 25, 2020
Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancerSebastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, et al.
Journal of Cancer Research and Clinical Oncology|November 18, 2011
Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicityNicolai Härtel, Thomas Klag, Benjamin Hanfstein, et al.
Pageof 13